Pozen faces more problems with 'GI-friendly' aspirin
This article was originally published in Scrip
Executive Summary
Pozen has hit another setback with its 'GI-friendly' aspirin candidate, PA32540, having failed to convince the US FDA that the product is bioequivalent to enteric-coated (EC) aspirin.